Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen

S. J. Jacobus, S. V. Rajkumar, M. Weiss, A. K. Stewart, E. A. Stadtmauer, N. S. Callander, L. M. Dreosti, M. Q. Lacy, R. Fonseca

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen'. Together they form a unique fingerprint.